TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Paras Biopharmaceuticals Finland Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
191
|
566 | |
Financial expenses |
163
|
46
|
10 |
Earnings before taxes |
-8,830
|
-3,846
|
-2,645 |
Total assets |
28,882
|
4,924
|
1,418 |
Current assets |
19,478
|
713
|
209 |
Current liabilities |
4,621
|
3,161
|
2,293 |
Equity capital |
19,258
|
338
|
-1,227 |
- share capital |
29
|
1,452
|
29 |
Employees (average) | 15 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
66.7%
|
6.9%
|
-86.5% |
Turnover per employee | 13 | ||
Profit as a percentage of turnover |
-4623.0%
|
-679.5% | |
Return on assets (ROA) |
-30.0%
|
-77.2%
|
-185.8% |
Current ratio |
421.5%
|
22.6%
|
9.1% |
Return on equity (ROE) |
-45.9%
|
-1137.9%
|
215.6% |
Change turnover | -402 | ||
Change turnover % | -68% | ||
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.